EcoDrugPlus

Phosphodiesterase 4d

Ensembl ID : ENSELUG00000002131
Gene Symbol: PDE4D
3 Cross references
205 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSELUG00000018270
Gene Symbol: PDE4D
3 Cross references
208 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSELUG00000011916
Gene Symbol: PDE5A
3 Cross references
209 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSELUG00000009801
Gene Symbol: PDE7A
4 Cross references
167 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSELUG00000014968
Gene Symbol: PDE7A
1 Cross references
215 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSELUG00000016088
Gene Symbol: PDE9A
4 Cross references
192 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSELUG00000007879
Gene Symbol: PIK3R1
3 Cross references
203 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSELUG00000012532
Gene Symbol: PIK3R2
3 Cross references
191 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSELUG00000003383
Gene Symbol: PIK3R3
3 Cross references
199 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSELUG00000006043
Gene Symbol: PIK3R5
3 Cross references
202 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSELUG00000007903
Gene Symbol: PIK3R1
1 Cross references
197 Possible Orthologues:

Phospholipase A2

Ensembl ID : ENSELUG00000020557
Gene Symbol: LOC105013229
3 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).